Data on Rectal Cancer Reported by a Researcher at Maria Sklodowska-Curie National Research Institute of Oncology [Randomized clinical trial on accelerated preoperative hyperfractionated radiotherapy (HART) vs preoperative hyperfractionated...].

Předmět:	CANCER chemotherapy TREATMENT effectiveness MEDICAL research CLINICAL trials REPORTERS & reporting RECTAL cancer RADIOTHERAPY
Zdroj:	Clinical Oncology Week; 9/24/2024, p148-148, 1p
Abstrakt:	A new report discusses research findings on rectal cancer, comparing the effectiveness of two treatment methods. The study aimed to compare the rates of pathological response after reoperative hyperfractionated radiotherapy with chemotherapy (HART-CT) versus preoperative hyperfractionated radiotherapy (HART) in patients with resectable rectal cancer. The analysis showed that the HART-CT arm had a significantly higher chance of achieving a complete response compared to HART. However, the differences in overall survival and disease-free survival were not statistically significant. The study suggests that the HART-CT treatment may improve pathological response rates and potentially lead to better clinical outcomes. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu